Bio Key International Stock Current Valuation
| BKYI Stock | USD 0.88 0.04 4.76% |
Valuation analysis of BIO Key International helps investors to measure BIO Key's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The BIO Key's current Enterprise Value Over EBITDA is estimated to increase to -0.19. The BIO Key's current Enterprise Value Multiple is estimated to increase to -0.19. Fundamental drivers impacting BIO Key's valuation include:
Price Book 19.7506 | Enterprise Value 3.3 M | Enterprise Value Ebitda (0.74) | Price Sales 0.3754 | Enterprise Value Revenue 0.4512 |
Undervalued
Today
Please note that BIO Key's price fluctuation is out of control at this time. Calculation of the real value of BIO Key International is based on 3 months time horizon. Increasing BIO Key's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since BIO Key is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BIO Stock. However, BIO Key's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.88 | Real 1.12 | Target 2.0 | Hype 0.83 | Naive 0.57 |
The intrinsic value of BIO Key's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence BIO Key's stock price.
Estimating the potential upside or downside of BIO Key International helps investors to forecast how BIO stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BIO Key more accurately as focusing exclusively on BIO Key's fundamentals will not take into account other important factors: BIO Key International Company Current Valuation Analysis
BIO Key's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current BIO Key Current Valuation | 3.29 M |
Most of BIO Key's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIO Key International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
BIO Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for BIO Key is extremely important. It helps to project a fair market value of BIO Stock properly, considering its historical fundamentals such as Current Valuation. Since BIO Key's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BIO Key's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BIO Key's interrelated accounts and indicators.
Click cells to compare fundamentals
BIO Current Valuation Historical Pattern
Today, most investors in BIO Key Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BIO Key's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of BIO Key current valuation as a starting point in their analysis.
BIO Key Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, BIO Key International has a Current Valuation of 3.29 M. This is 99.95% lower than that of the Software sector and 99.83% lower than that of the Information Technology industry. The current valuation for all United States stocks is 99.98% higher than that of the company.
BIO Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIO Key's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIO Key could also be used in its relative valuation, which is a method of valuing BIO Key by comparing valuation metrics of similar companies.BIO Key is currently under evaluation in current valuation category among its peers.
BIO Fundamentals
| Return On Equity | -4.58 | ||||
| Return On Asset | -0.56 | ||||
| Profit Margin | (0.92) % | ||||
| Operating Margin | (1.45) % | ||||
| Current Valuation | 3.29 M | ||||
| Shares Outstanding | 3.11 M | ||||
| Shares Owned By Insiders | 5.57 % | ||||
| Shares Owned By Institutions | 5.02 % | ||||
| Number Of Shares Shorted | 865.18 K | ||||
| Price To Earning | (2.55) X | ||||
| Price To Book | 19.75 X | ||||
| Price To Sales | 0.38 X | ||||
| Revenue | 7.75 M | ||||
| Gross Profit | 3.44 M | ||||
| EBITDA | (7.85 M) | ||||
| Net Income | (8.52 M) | ||||
| Cash And Equivalents | 4.89 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 365.35 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.50 X | ||||
| Book Value Per Share | (0.58) X | ||||
| Cash Flow From Operations | (3.79 M) | ||||
| Short Ratio | 0.16 X | ||||
| Earnings Per Share | (8.66) X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 43 | ||||
| Beta | 0.25 | ||||
| Market Capitalization | 3.25 M | ||||
| Total Asset | 4.52 M | ||||
| Retained Earnings | (125.01 M) | ||||
| Working Capital | (591.23 K) | ||||
| Current Asset | 9.88 M | ||||
| Current Liabilities | 1.72 M | ||||
| Net Asset | 4.52 M |
About BIO Key Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIO Key International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIO Key using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIO Key International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:Check out BIO Key Piotroski F Score and BIO Key Altman Z Score analysis. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share 6.323 | Quarterly Revenue Growth (0.41) | Return On Assets (0.56) | Return On Equity (4.58) |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.